Your browser doesn't support javascript.
loading
SGLT-2 inhibitor intervention in diabetes mellitus patients can reduce the incidence of renal injury and adverse events.
Tao, Xiaoyan; Pan, Tianrong; Zhong, Xing; Du, Yijun; Zhang, Ping.
Affiliation
  • Tao X; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University Hefei 236600, Anhui Province, China.
  • Pan T; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University Hefei 236600, Anhui Province, China.
  • Zhong X; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University Hefei 236600, Anhui Province, China.
  • Du Y; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University Hefei 236600, Anhui Province, China.
  • Zhang P; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University Hefei 236600, Anhui Province, China.
Am J Transl Res ; 13(4): 2731-2737, 2021.
Article in En | MEDLINE | ID: mdl-34017435
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Incidence_studies / Risk_factors_studies Language: En Journal: Am J Transl Res Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Incidence_studies / Risk_factors_studies Language: En Journal: Am J Transl Res Year: 2021 Document type: Article Affiliation country: Country of publication: